Zhejiang AngLiKang Pharmaceutical CO.,LTD. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 424.51 million compared to CNY 338.21 million a year ago. Revenue was CNY 424.51 million compared to CNY 338.21 million a year ago.

Net income was CNY 47.07 million compared to CNY 39.09 million a year ago. Basic earnings per share from continuing operations was CNY 0.2345 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.2345 compared to CNY 0.2 a year ago.